{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:05:23Z","timestamp":1761609923366,"version":"3.41.0"},"reference-count":36,"publisher":"Tohoku University Medical Press","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tohoku J. Exp. Med."],"published-print":{"date-parts":[[2017]]},"DOI":"10.1620\/tjem.242.53","type":"journal-article","created":{"date-parts":[[2017,5,23]],"date-time":"2017-05-23T22:08:44Z","timestamp":1495577324000},"page":"53-62","source":"Crossref","is-referenced-by-count":7,"title":["Remission Induction Therapy with Rituximab for Microscopic Polyangiitis: A Feasibility Study"],"prefix":"10.1620","volume":"242","author":[{"given":"Ayako","family":"Saito","sequence":"first","affiliation":[{"name":"Department of Nephrology, Japanese Red Cross Ishinomaki Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoichi","family":"Takeuchi","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Japanese Red Cross Ishinomaki Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saeko","family":"Kagaya","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Japanese Red Cross Ishinomaki Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshie","family":"Ojima","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Japanese Red Cross Ishinomaki Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirotaka","family":"Fukami","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Japanese Red Cross Ishinomaki Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Sato","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Japanese Red Cross Ishinomaki Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Matsuda","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Japanese Red Cross Ishinomaki Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tasuku","family":"Nagasawa","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Japanese Red Cross Ishinomaki Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"622","reference":[{"key":"1","unstructured":"Berden, A.E., Ferrario, F., Hagen, E.C., Jayne, D.R., Jennette, J.C., Joh, K., Neumann, I., No\u00ebl, L.H., Pusey, C.D., Waldherr, R., Bruijn, J.A. &amp; Bajema, I.M. (2010) Histopathologic classification of ANCA-associated glomerulonephritis. <i>J. Am. Soc. Nephrol.<\/i>, 21, 1628-1636."},{"key":"2","unstructured":"De Groot, K., Rasmussen, N., Bacon, P.A., Tervaert, J.W.C., Feighery, C., Gregorini, G., Gross, W.L., Luqmanim, R. &amp; Jayne, D.R. (2005) Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis. <i>Arthritis Rheum.<\/i>, 52, 2461-2469."},{"key":"3","doi-asserted-by":"crossref","unstructured":"Exley, A.R., Bacon, P.A., Luqmani, R.A., Kitas, G.D., Gordon, C., Savage, C.O. &amp; Adu, D. (1997) Development and initial validation of the vasculitis damage index for the standardized clinical assessment of damage in the systemic vasculitides. <i>Arthritis Rheum.<\/i>, 40, 371-380.","DOI":"10.1002\/art.1780400222"},{"key":"4","doi-asserted-by":"crossref","unstructured":"Fleury, I., Chevret, S., Pfreundschuh, M., Salles, G., Coiffier, B., van Oers, M.H., Gisselbrecht, C., Zucca, E., Herold, M., Ghielmini, M. &amp; Thieblemont, C. (2016) Rituximab and risk of second primary malignancies in patients with non-Hodgkin lymphoma: a systematic review and meta-analysis. <i>Ann. Oncol.<\/i>, 27, 390-397.","DOI":"10.1093\/annonc\/mdv616"},{"key":"5","unstructured":"Fujimoto, S., Uezono, S., Hisanaga, S., Fukudome, K., Kobayashi, S., Suzuki, K., Hashimoto, H., Nakao, H. &amp; Nunoi, H. (2006) Incidence of ANCA-associated primary renal vasculitis in the miyazaki prefecture: the first population-based, retrospective, epidemiologic survey in Japan. <i>Clin. J. Am. Soc. Nephrol.<\/i>, 1, 1016-1022."},{"key":"6","doi-asserted-by":"crossref","unstructured":"Fujimoto, S., Watts, R.A., Kobayashi, S., Suzuki, K., Jayne, D.R., Scott, D.G., Hashimoto, H. &amp; Nunoi, H. (2011) Comparison of the epidemiology of anti-neutrophil cytoplasmic antibody-associated vasculitis between Japan and the U.K. <i>Rheumatology<\/i> (<i>Oxford<\/i>), 50, 1916-1920.","DOI":"10.1093\/rheumatology\/ker205"},{"key":"7","unstructured":"Geetha, D., Specks, U., Stone, J.H., Merkel, P.A., Seo, P., Spieram R., Langford, C.A., Hoffman, G.S., Kallenberg, C.G., St. Clair, E.W., Fessler, B.J., Ding, L., Tchao, N.K., Ikle, D., Jepson, B., et al. (2015) Rituximab versus cyclophosphamide for ANCA-associated vasculitis with renal involvement. <i>J. Am. Soc. Nephrol.<\/i>, 26, 976-985."},{"key":"8","unstructured":"Greco, A., De Virgilio, A., Rizzo, M.I., Gallo, A., Magliulo, G., Fusconi, M., Ruoppolo, G., Tombolini, M., Turchetta, R. &amp; de Vincentiis, M. (2015) Microscopic polyangiitis: Advances in diagnostic and therapeutic approaches. <i>Autoimmun. Rev.<\/i>, 14, 837-844."},{"key":"9","unstructured":"Jennette, J.C., Falk, R.J., Andrassy, K., Bacon, P.A., Churg, J., Gross, W.L., Hagen, E.C., Hoffman, G.S., Hunder, G.G., Kallenberg, C.G., Mccluskey, R.T., Sinico, R.A., Rees, A.J., Van Es, L.A., Waldherr, R. &amp; Wiik, A. (1994) Nomenclature of systemic vasculitides. Proposal of an international consensus conference. <i>Arthritis Rheum.<\/i>, 37, 187-192."},{"key":"10","unstructured":"Jennette, J.C., Falk, R.J., Bacon, P.A., Basu, N., Cid, M.C., Ferrario, F., Flores-Suarez, L.F., Gross, W.L., Guillevin, L., Hagen, E.C., Hoffman, G.S., Jayne, D.R., Kallenberg, C.G., Lamprecht, P., Langford, C.A., et al. (2013) 2012 Revised International Chapel Hill consensus conference nomenclature of vasculitides. <i>Arthritis Rheum.<\/i>, 65, 1-11."},{"key":"11","unstructured":"Kamei, K., Ito, S., Nozu, K., Fujinaga, S., Nakayama, M., Sako, M., Saito, M., Yoneko, M. &amp; Iijima, K. (2009) Single dose of rituximab for refractory steroid-dependent nephrotic syndrome in children. <i>Pediatr. Nephrol.<\/i>, 24, 1321-1328."},{"key":"12","unstructured":"Khan, I. &amp; Watts, R.A. (2013) Classification of ANCA-associated vasculitis. <i>Curr. Rheumatol. Rep.<\/i>, 15, 383."},{"key":"13","unstructured":"Knight, A., Sundstr\u00f6m, Y., B\u00f6rjesson, O., Bruchfeld, A., Malmstr\u00f6m, V. &amp; Gunnarsson, I. (2016) Late-onset neutropenia after rituximab in ANCA-associated vasculitis. <i>Scand. J. Rheumatol.<\/i>, 45, 404-407."},{"key":"14","unstructured":"Koyama, A., Yamagata, K., Makino, H., Arimura, Y., Wada, T., Nitta, K., Nihei, H., Muso, E., Taguma, Y., Shigematsu, H., Sakai, H., Tomino, Y. &amp; Matsuo, S.; Japan RPGN Registry Group (2009) A nationwide survey of rapidly progressive glomerulonephritis in Japan: etiology, prognosis and treatment diversity. <i>Clin. Exp. Nephrol.<\/i>, 13, 633-650."},{"key":"15","unstructured":"Mahr, A., Heijl, C., Le Guenno, G. &amp; Faurschou, M. (2013) ANCA-associated vasculitis and malignancy: current evidence for cause and consequence relationships. <i>Best Pract. Res.Clin. Rheumatol.<\/i>, 27, 45-56."},{"key":"16","unstructured":"Matsuo, S., Imai, E., Horio, M., Yasuda, Y., Tomita, K., Nitta, K., Yamagata, K., Tomino, Y., Yokoyama, H. &amp; Hishida, A.; Collaborators developing the Japanese equation for estimated GFR (2009) Revised equations for estimated GFR from serum creatinine in Japan. <i>Am. J. Kidney Dis.<\/i>, 53, 982-992."},{"key":"17","doi-asserted-by":"crossref","unstructured":"Mukhtyar, C., Guillevin, L., Cid, M.C., Dasgupta, B., de Groot, K., Gross, W., Hauser, T., Hellmich, B., Jayne, D., Kallenberg, C.G., Merkel, P.A., Raspe, H., Salvaranim, C., Scott, D.G., Stegeman, C., et al. (2009a) EULAR recommendations for the management of primary small and medium vessel vasculitis. <i>Ann. Rheum. Dis.<\/i>, 68, 310-317.","DOI":"10.1136\/ard.2008.088096"},{"key":"18","doi-asserted-by":"crossref","unstructured":"Mukhtyar, C., Lee, R., Brown, D., Carruthers, D., Dasgupta, B., Dubey, S., Flossmann, O., Hall, C., Hollywood, J., Jayne, D., Jones, R., Lanyon, P., Muir, A., Scott, D., Young, L. &amp; Lugmani, R.A. (2009b) Modification and validation of the Birmingham Vasculitis Activity Score (version 3). <i>Ann. Rheum. Dis.<\/i>, 68, 1827-1832.","DOI":"10.1136\/ard.2008.101279"},{"key":"19","unstructured":"Nagafuchi, H., Atsumi, T., Hatta, K., Muso, E., Takeno, M., Yamada, H. &amp; Ozaki, S. (2015) Long-term safety and efficacy of rituximab in 7 Japanese patients with ANCA-associated vasculitis. <i>Mod. Rheumatol.<\/i>, 25, 603-608."},{"key":"20","unstructured":"Ochi, A., Takei, T., Nakayama, K., Iwasaki, C., Kamei, D., Tsuruta, Y., Shimizu, A., Shiohira, S., Moriyama, T., Itabashi, M., Mochizuki, T., Uchida, K., Tsuchiya, K., Hattori, M. &amp; Nitta, K. (2012) Rituximab treatment for adult patients with focal segmental glomerulosclerosis. <i>Intern. Med.<\/i>, 51, 759-762."},{"key":"21","unstructured":"Ozaki, S. (2007) ANCA-associated vasculitis: diagnostic therapeutic strategy. <i>Allergol. Int.<\/i>, 56, 87-96."},{"key":"22","doi-asserted-by":"crossref","unstructured":"Ozaki, S., Atsumi, T., Hayashi, T., Ishizu, A., Kobayashi, S., Kumagai, S., Kurihara, Y., Kurokawa, M.S., Makino, H., Nagafuchi, H., Nakabayashi, K., Nishimoto, N., Suka, M., Tomino, Y., Yamada, H., et al. (2012) Severity-based treatment for Japanese patients with MPO-ANCA-associated vasculitis: the JMAAV study. <i>Mod. Rheumatol.<\/i>, 22, 394-404.","DOI":"10.3109\/s10165-011-0525-5"},{"key":"23","doi-asserted-by":"crossref","unstructured":"Pankhurst, T., Savage, C.O., Gordon, C. &amp; Harper, L. (2004) Malignancy is increased in ANCA-associated vasculitis. <i>Rheumatology <\/i>(<i>Oxford<\/i>), 43, 1532-1535.","DOI":"10.1093\/rheumatology\/keh374"},{"key":"24","unstructured":"Savage, C.O., Winearls, C.G., Evans, D.J., Rees, A.J. &amp; Lockwood, C.M. (1985) Microscopic polyarteritis: presentation, pathology and prognosis. <i>Q. J. Med.<\/i>, 56, 467-483."},{"key":"25","unstructured":"Serra, A., Cameron, J.S., Turner, D.R., Hartley, B., Ogg, C.S., Neild, G.H., Williams, D.G., Taube, D., Brown, C.B. &amp; Hicks, J.A. (1984) Vasculitis affecting the kidney: presentation, histopathology and long-term outcome. <i>Q. J. Med.<\/i>, 53, 181-207."},{"key":"26","unstructured":"Shiraki, A., Ando, M., Shindoh, J., Abe, T., Wakahara, K., Makino, Y., Asano, T., Nakashima, H., Hase, T., Shigemitsu, K., Horiba, M. &amp; Shimokata, K. (2007) Prevalence of myeloperoxidase-anti-neutrophil cytoplasmic antibody (MPO-ANCA) in patients with interstitial pneumonia. <i>J. Jpn. Respir. Soc.<\/i>, 45, 921-926 (in Japanese)."},{"key":"27","unstructured":"Specks, U., Merkel, P.A., Seo, P., Spiera, R., Langford, C.A., Hoffman, G.S., Kallenberg, C.G., St. Clair, E.W., Fessler, B.J., Ding, L., Viviano, L., Tchao, N.K., Phippard, D.J., Asare, A.L., Lim, N., et al. (2013) Efficacy of remission-induction regimens for ANCA-associated vasculitis. <i>N. Engl. J. Med.<\/i>, 369, 417-427."},{"key":"28","unstructured":"Stone, J.H., Merkel, P.A., Spiera, R., Seo, P., Langford, C.A., Hoffman, G.S., Kallenberg, C.G., St. Clair, E.W., Turkiewicz, A., Tchao, N.K., Webber, L., Ding, L., Sejismundo, L.P., Mieras, K., Weitzenkamp, D., et al. (2010) Rituximab versus cyclophosphamide for ANCA-associated vasculitis. <i>N. Engl. J. Med.<\/i>, 363, 221-232."},{"key":"29","doi-asserted-by":"crossref","unstructured":"Turner-Stokes, T., Sandhu, E., Pepper, R.J., Stolagiewicz, N.E., Ashley, C., Dinneen, D., Howie, A.J., Salama, A.D., Burns, A. &amp; Little, M.A. (2014) Induction treatment of ANCA-associated vasculitis with a single dose of rituximab. <i>Rheumatology <\/i>(<i>Oxford<\/i>), 53, 1395-1403.","DOI":"10.1093\/rheumatology\/ket489"},{"key":"30","doi-asserted-by":"crossref","unstructured":"Watts, R.A., Lane, S., Hanslik, T., Hauser, T., Hellmich, B., Koldingsnes, W., Mahr, A., Segelmark, M., Cohen-Tervaert, J.W. &amp; Scott, D. (2007) Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies. <i>Ann. Rheum. Dis.<\/i>, 66, 222-227.","DOI":"10.1136\/ard.2006.054593"},{"key":"31","unstructured":"Watts, R.A., Scott, D.G., Jayne, D.R., Ito-Ihara, T., Muso, E., Fujimoto, S., Harabuchi, Y., Kobayashi, S., Suzuki, K. &amp; Hashimoto, H. (2008) Renal vasculitis in Japan and the UK: are there differences in epidemiology and clinical phenotype? <i>Nephrol. Dial. Transplan.<\/i>, 23, 3928-3931."},{"key":"32","doi-asserted-by":"crossref","unstructured":"Wiik, A. (2002) Rational use of ANCA in the diagnosis of vasculitis. <i>Rheumatology <\/i>(<i>Oxford<\/i>), 41, 481-483.","DOI":"10.1093\/rheumatology\/41.5.481"},{"key":"33","doi-asserted-by":"crossref","unstructured":"Yamagata, K., Hirayama, K., Mase, K., Yamaguchi, N., Kobayashi, M., Takahashi, H. &amp; Koyama, A. (2005) Apheresis for MPO-ANCA-associated RPGN-indications and efficacy: lessons learned from Japan nationwide survey of RPGN. <i>J. Clin. Apher.<\/i>, 20, 244-251.","DOI":"10.1002\/jca.20035"},{"key":"34","unstructured":"Yamagata, K., Usui, J., Saito, C., Yamaguchi, N., Hirayama, K., Mase, K., Kobayashi, M., Koyama, A., Sugiyama, H., Nitta, K., Wada, T., Muso, E., Arimura, Y., Makino, H. &amp; Matsuo, S. (2012) ANCA-associated systemic vasculitis in Japan: clinical features and prognostic changes. <i>Clin. Exp. Nephrol.<\/i>, 16, 580-588."},{"key":"35","unstructured":"Yates, M., Watts, R.A., Bajema, I.M., Cid, M.C., Crestani, B., Hauser, T., Hellmich, B., Holle, J.U., Laudien, M., Little, M.A., Luqmani, R.A., Mahr, A., Merkel, P.A., Mills, J., Mooney, J., et al. (2016) EULAR\/ERA-EDTA recommendations for the management of ANCA-associated vasculitis. <i>Ann. Rheum. Dis.<\/i>, 75, 1583-1594."},{"key":"36","doi-asserted-by":"crossref","unstructured":"Yumura, W., Kobayashi, S., Suka, M., Hayashi, T., Ito, S., Nagafuchi, H., Yamada, H. &amp; Ozaki, S.; JMAAV Study Group (2014) Assessment of the Birmingham vasculitis activity score in patients with MPO-ANCA-associated vasculitis: sub-analysis from a study by the Japanese Study Group for MPO-ANCA-associated vasculitis. <i>Mod. Rheumatol.<\/i>, 24, 304-309.","DOI":"10.3109\/14397595.2013.854075"}],"container-title":["The Tohoku Journal of Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tjem\/242\/1\/242_53\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T19:28:27Z","timestamp":1750274907000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tjem\/242\/1\/242_53\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1620\/tjem.242.53","relation":{},"ISSN":["0040-8727","1349-3329"],"issn-type":[{"type":"print","value":"0040-8727"},{"type":"electronic","value":"1349-3329"}],"subject":[],"published":{"date-parts":[[2017]]}}}